Hypolipidaemic and antiplatelet agents

Author： Kaliszan Roman   Siluk Danuta   Chilmonczyk Zdzislaw  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.8, 2001-08, pp. : 1301-1327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Antiplatelet Agents

By  

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 577-589

Bentham Science Publishers

Access to resources Recommend Favorite

Historical Hallmarks of Anticoagulation and Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1857-1861

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4610-4616

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic differences of current thienopyridine antiplatelet agents

By Fareed Jawed   Jeske Walter   Thethi Indermohan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 3, 2013-03 ,pp. : 307-317

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet agents - a little goes a long way in ACS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite